JaxBio

Meet Noa Gilat, our brilliant VP of R&D! 🚀 Noa is a key player in bringing our groundbreaking technology to life. With a sharp mind and a passion for innovation, she oversees our R&D team and ensures every experiment is a step closer to revolutionizing healthcare. 🧪🔬 Before joining JaxBio, Noa was part of our co-founder Yuval Ebenstein’s lab at the university, where she contributed to the early proof-of-concept work that laid the foundation for our company. 🎓 When she’s not busy leading our R&D efforts, Noa enjoys spending time with her family and recently took up running. 🏃♀️🏃♂️ We are lucky to have Noa on our team! #innovation #biotech

As this year's Hanukkah and Christmas fall on the same day, we want to extend warm holiday greetings to all our family, friends, and loved ones. May your celebrations be filled with joy, light, and love. Wishing you a season of peace, happiness, and togetherness as we cherish the traditions that bring us closer. Happy Holidays!

Early detection of cancer can significantly improve treatment outcomes and survival rates by allowing interventions at a more manageable stage. #earlydetection #precisionmedicine #liquidbiopsies

Discover the key takeaways from Dr. Massimo Cristofanilli, MD, FACP on OncLive as he discusses the advancements in liquid biopsy technology for breast cancer patients. #earlydetection #breastcancer #liquidbiopsies https://lnkd.in/d44_n2Cs

Liquid biopsies detecting more than just cancers!

We are incredibly thankful for our wonderful Jaxbio family and everyone who has supported us throughout the year. Wishing you and your loved ones a happy Thanksgiving! 🦃✨

The recent Nature Magazine article highlights the growing potential of liquid biopsies in cancer care. At JaxBio, we're tackling one of the biggest challenges - sensitivity. Our innovative approach identifies thousands of cancer-specific biomarkers in blood, transforming early detection. While current liquid biopsies face sensitivity challenges, our technology pushes boundaries. We're making faster, more accurate cancer detection a reality with our simple, next-day process that's not just highly sensitive, but also affordable and scalable. Our AI-driven platform analyzes both genetic and epigenetic profiles, enhancing early-stage cancer detection capabilities. This aligns with the field's progress towards more sensitive and specific diagnostic tools. Stay tuned as we continue to advance liquid biopsies and reshape the future of cancer care! 💪🏼🔬 #CancerDiagnostics #LiquidBiopsy #MedicalInnovation

Meet Yael Michaeli our CTO that has been with us from the get-go, bringing her brilliant mind to our team at JaxBio! 🧬🔬 With a PhD in tumor immunology and a decade of experience managing cutting-edge genomics research, Yael drives our innovative liquid biopsy technology. Her analytical approach and patient nature make her the perfect problem-solver for our most complex challenges. When she's not revolutionizing cancer diagnostics, you might find Yael unwinding with yoga, reading, or learning to play the piano with her daughters. Because sometimes, the best ideas come when you're perfectly relaxed! 🧘♀️ At JaxBio, we're not just pushing the boundaries of science – we're doing it with a team that knows how to work hard and recharge right. Thanks for being our rock, Yael! 🚀💪 #JaxBio #WomenInSTEM #CancerResearch

It's Lung Cancer Awareness Month 2024, check out these shocking stats and see how JaxBio is getting ready to change them. #lungcancer #earlydetection #lungcancer2024

As we approach Lung Cancer Awareness Month, we must emphasize the importance of advocacy and education surrounding biomarker testing in lung cancer. At JaxBio, we are excited to focus on liquid biopsy technology for lung cancer detection, which holds great promise for improving patient outcomes. Dr. David P. Carbone, MD, PhD, succinctly highlights the importance of this approach: "𝐑𝐞𝐚𝐥𝐥𝐲, 𝐲𝐨𝐮 𝐬𝐡𝐨𝐮𝐥𝐝 𝐚𝐬𝐤 𝐭𝐡𝐞 𝐬𝐮𝐫𝐠𝐞𝐨𝐧 𝐭𝐨 𝐝𝐨 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐚𝐧𝐝 𝐠𝐞𝐭 𝐭𝐡𝐚𝐭 𝐫𝐞𝐬𝐮𝐥𝐭 𝐛𝐚𝐜𝐤 𝐭𝐨 𝐦𝐚𝐤𝐞 𝐬𝐮𝐫𝐞 𝐲𝐨𝐮'𝐫𝐞 𝐧𝐨𝐭 𝐦𝐢𝐬𝐬𝐢𝐧𝐠 𝐚𝐧 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐭𝐨 𝐢𝐦𝐩𝐫𝐨𝐯𝐞 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐟𝐫𝐨𝐦 𝐬𝐮𝐫𝐠𝐞𝐫𝐲 𝐨𝐫 𝐜𝐡𝐞𝐦𝐨/𝐫𝐚𝐝𝐢𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐬𝐭𝐚𝐠𝐞 𝐈𝐈𝐈, 𝐛𝐞𝐜𝐚𝐮𝐬𝐞 𝐭𝐡𝐞𝐬𝐞 𝐨𝐩𝐭𝐢𝐨𝐧𝐬 𝐝𝐫𝐚𝐦𝐚𝐭𝐢𝐜𝐚𝐥𝐥𝐲 𝐢𝐦𝐩𝐫𝐨𝐯𝐞 𝐩𝐫𝐨𝐠𝐫𝐞𝐬𝐬𝐢𝐨𝐧-𝐟𝐫𝐞𝐞 𝐬𝐮𝐫𝐯𝐢𝐯𝐚𝐥 𝐚𝐧𝐝 𝐨𝐯𝐞𝐫𝐚𝐥𝐥 𝐬𝐮𝐫𝐯𝐢𝐯𝐚𝐥, 𝐚𝐧𝐝 𝐢𝐭'𝐬 𝐚 𝐬𝐡𝐚𝐦𝐞 𝐭𝐨 𝐦𝐢𝐬𝐬 𝐭𝐡𝐞𝐦." Liquid biopsies are revolutionizing cancer diagnosis and treatment by allowing us to analyze a simple blood sample to detect the presence of cancer and identify genetic mutations. 𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬: - Minimally Invasive: Just a blood draw reduces patient discomfort - Faster Results: Typically available within 5-7 days for quicker treatment decisions - Real-Time Monitoring: Enables ongoing assessment of treatment response While liquid biopsies are not 100% sensitive and should complement traditional biopsies, they provide critical insights that can guide effective therapy choices. As David Carbone emphasizes, starting the wrong treatment can have serious consequences. Listen to Dr. David P. Carbone's full discussion here >> [Liquid Biopsy Advances: Vital Role in Biomarker Testing in Lung Cancer] (https://lnkd.in/g3Uq8uxV). #lungcancer #cancerdiagnostics #liquidbiopsy